Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Take home message GLP-1 weight loss injections are evidence-based treatments supported by extensive clinical research, which has shown 15-25% weight loss
Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use these medications
Features & Benefits
For further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the Trademarks and Trade Names All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are referenced in this press release, the property of their respective owners
US$ 28.85
US$ 24.78
US$ 22.99
US$ 20.43
US$ 22.63
US$ 23.14
US$ 28.72
